Phase II Clinical Trial of Clenbuterol in Adult Patients With Pompe Disease

Summary

The goals of this study are to determine safety and efficacy with regard to motor function of oral clenbuterol in combination with ERT in subjects with LOPD

Timeline

Start

2023-01-01

Primary completion

2025-06-30

Completion

2025-12-30

Drugs

Indications